A Study to Investigate the Effect of Different Particle Sizes on the Single-dose Pharmacokinetics of Rilpivirine After Intramuscular Injection of a Long-acting Nanosuspension in Healthy Participants
Clinical trial NCT03127189 · COMPLETED
Trial details
- NCT number
- NCT03127189
- Sponsor
- Janssen Research & Development, LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-04-20
- Primary completion
- 2018-04-10
- Enrollment
- 110
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.